While Erdem et al. [26] found significantly reduced plasma apelin levels in obese subjects with untreated type 2 diabetes compared to non-diabetic subjects, Li et al. [27] have found elevated plasma apelin levels in people with impaired glucose tolerance and type 2 diabetes mellitus. This evidence concerns the gene APLN and Impaired glucose tolerance.